News brief­ing: PureTech plans Nas­daq de­but with sec­ondary list­ing; GoodRx prices $725M IPO

Lon­don Stock Ex­change-list­ed PureTech Health an­nounced Wednes­day that it’s look­ing to ex­tend to Nas­daq. But due to its “strong cash po­si­tion,” the biotech says it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER